Pulse Oximeters Market Size, Share, Growth Analysis, By Component (Monitors, Sensors), By Type (Portable, Tabletop/Bed Side), By Age Group (Adult, Pediatric), By End Use, By Region -Industry Forecast 2026-2033

Global Pulse Oximeter market size was valued at USD 2.91 Billion in 2024 and is poised to grow from USD 3.14 Billion in 2025 to USD 5.72 Billion by 2033, growing at a CAGR of 7.8% in the forecast period (2026–2033).

The global pulse oximeters market is extremely competitive worldwide, with major competitors spearheading research and growth. The market is also quite fragmented due to the presence of various global and regional manufacturers. Key players have adopted various strategies such as partnerships, new product launch & commercialization, and vertical integration for business expansion. A recent example of such a partnership is GE HealthCare’s partnership with Raydiant Oximetry in May 2025. This was done to integrate Raydiant’s Lumerah foetal pulse oximetry technology into its perinatal monitoring platforms. Further, many companies have increased their investment in R&D to innovate new products which has helped them to strengthen their position in the global market. 'Medtronic plc (Ireland)', 'Masimo Corporation (United States)', 'Koninklijke Philips N.V. (Netherlands)', 'Nonin Medical, Inc. (United States)', 'Nihon Kohden Corporation (Japan)', 'GE Healthcare (United States)', 'Contec Medical Systems Co., Ltd. (China)', 'ICU Medical, Inc. (United States)', 'Drägerwerk AG & Co. KGaA (Germany)', 'OSI Systems Inc. (United States)', 'Honeywell International Inc. (United States)', 'Meditech Group (China)', 'Medline Industries, LP (United States)', 'Choicemmed (China)', 'Nureca Limited (Dr Trust) (India)', 'Shanghai Berry Electronic Tech Co., Ltd. (China)', 'Promed Group Co., Ltd. (China)', 'HUM GmbH (Germany)', 'Beurer GmbH (Germany)', 'Shenzhen Aeon Technology Co., Ltd. (China)'

The burden of respiratory conditions such as COPD, asthma, and sleep apnea has been on the rise across the globe. According to the WHO, asthma affected approximately 262 million people in 2019. A study in JAMA estimated the global COPD prevalence to reach 600 million cases worldwide by 2050 which is a 23% rise from 2020 numbers. This creates a need for pulse oximeters so that these devices can provide monitoring of oxygen saturation in real-time. The devices hold special importance for chronic disease management. The growing aging population, which is more prone to respiratory illnesses, also validates the need for continuous SpO₂ monitoring at home and in clinical settings.

Regulatory Emphasis on Racial Equity is Creating a New Wave of Innovation:

Why is North America Leading Pulse Oximeters Market in 2024?